Normal somatomedin and somatomedin receptors in achondroplastic dwarfism

Ronald (Ron) Rosenfeld, R. L. Hintz

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It has been proposed that the basic abnormality in achondroplasia may be a quantitative defect in endochondral new bone formation secondary to decreased synthesis of somatomedin (SM) or abnormal binding of SM to specific receptors. To test this hypothesis, we have measured plasma SM levels and SM receptors on circulating mononuclear cells obtained from 5 achondroplastic dwarfs and 5 age-matched controls. Plasma SM levels were 0.82 ± 0.14 U/ml (mean ± S.E.M.) for the achondroplastic dwarfs and 0.90 ± 0.12 U/ml for the controls. The specific binding of 125I-SM to 50 X 106 mononuclear cells was 7.66 ± 1.11% for the dwarf group and 7.66 ± 1.16% for the controls. Achondroplastic and control cells possessed equal numbers of receptor sites and identical receptor affinity for SM. The data indicate that plasma SM levels and SM binding to circulating mononuclear cells are normal in achondroplastic dwarfs and suggest a primary intracellular defect.

Original languageEnglish (US)
Pages (from-to)76-79
Number of pages4
JournalHormone and Metabolic Research
Volume12
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Somatomedin Receptors
Somatomedins
Plasmas
Achondroplasia
Defects
Achondroplastic dwarfism
Osteogenesis
Bone
Scanning electron microscopy

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Normal somatomedin and somatomedin receptors in achondroplastic dwarfism. / Rosenfeld, Ronald (Ron); Hintz, R. L.

In: Hormone and Metabolic Research, Vol. 12, No. 2, 1980, p. 76-79.

Research output: Contribution to journalArticle

Rosenfeld, Ronald (Ron) ; Hintz, R. L. / Normal somatomedin and somatomedin receptors in achondroplastic dwarfism. In: Hormone and Metabolic Research. 1980 ; Vol. 12, No. 2. pp. 76-79.
@article{bbba963a522d44b89bba0845f8864174,
title = "Normal somatomedin and somatomedin receptors in achondroplastic dwarfism",
abstract = "It has been proposed that the basic abnormality in achondroplasia may be a quantitative defect in endochondral new bone formation secondary to decreased synthesis of somatomedin (SM) or abnormal binding of SM to specific receptors. To test this hypothesis, we have measured plasma SM levels and SM receptors on circulating mononuclear cells obtained from 5 achondroplastic dwarfs and 5 age-matched controls. Plasma SM levels were 0.82 ± 0.14 U/ml (mean ± S.E.M.) for the achondroplastic dwarfs and 0.90 ± 0.12 U/ml for the controls. The specific binding of 125I-SM to 50 X 106 mononuclear cells was 7.66 ± 1.11{\%} for the dwarf group and 7.66 ± 1.16{\%} for the controls. Achondroplastic and control cells possessed equal numbers of receptor sites and identical receptor affinity for SM. The data indicate that plasma SM levels and SM binding to circulating mononuclear cells are normal in achondroplastic dwarfs and suggest a primary intracellular defect.",
author = "Rosenfeld, {Ronald (Ron)} and Hintz, {R. L.}",
year = "1980",
language = "English (US)",
volume = "12",
pages = "76--79",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "2",

}

TY - JOUR

T1 - Normal somatomedin and somatomedin receptors in achondroplastic dwarfism

AU - Rosenfeld, Ronald (Ron)

AU - Hintz, R. L.

PY - 1980

Y1 - 1980

N2 - It has been proposed that the basic abnormality in achondroplasia may be a quantitative defect in endochondral new bone formation secondary to decreased synthesis of somatomedin (SM) or abnormal binding of SM to specific receptors. To test this hypothesis, we have measured plasma SM levels and SM receptors on circulating mononuclear cells obtained from 5 achondroplastic dwarfs and 5 age-matched controls. Plasma SM levels were 0.82 ± 0.14 U/ml (mean ± S.E.M.) for the achondroplastic dwarfs and 0.90 ± 0.12 U/ml for the controls. The specific binding of 125I-SM to 50 X 106 mononuclear cells was 7.66 ± 1.11% for the dwarf group and 7.66 ± 1.16% for the controls. Achondroplastic and control cells possessed equal numbers of receptor sites and identical receptor affinity for SM. The data indicate that plasma SM levels and SM binding to circulating mononuclear cells are normal in achondroplastic dwarfs and suggest a primary intracellular defect.

AB - It has been proposed that the basic abnormality in achondroplasia may be a quantitative defect in endochondral new bone formation secondary to decreased synthesis of somatomedin (SM) or abnormal binding of SM to specific receptors. To test this hypothesis, we have measured plasma SM levels and SM receptors on circulating mononuclear cells obtained from 5 achondroplastic dwarfs and 5 age-matched controls. Plasma SM levels were 0.82 ± 0.14 U/ml (mean ± S.E.M.) for the achondroplastic dwarfs and 0.90 ± 0.12 U/ml for the controls. The specific binding of 125I-SM to 50 X 106 mononuclear cells was 7.66 ± 1.11% for the dwarf group and 7.66 ± 1.16% for the controls. Achondroplastic and control cells possessed equal numbers of receptor sites and identical receptor affinity for SM. The data indicate that plasma SM levels and SM binding to circulating mononuclear cells are normal in achondroplastic dwarfs and suggest a primary intracellular defect.

UR - http://www.scopus.com/inward/record.url?scp=0018841991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018841991&partnerID=8YFLogxK

M3 - Article

C2 - 6245996

AN - SCOPUS:0018841991

VL - 12

SP - 76

EP - 79

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 2

ER -